Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-21 6:38 pm Sale | 2025-01-16 | 13D | RENEO PHARMACEUTICALS INC RPHM | RiverVest Venture Fund III, L.P. | 196,198 1.550% | -57,224![]() (-22.58%) | Filing History |
| 2025-01-10 11:05 am Sale | 2025-01-07 | 13D | SPRUCE BIOSCIENCES INC SPRB | RiverVest Venture Fund III, L.P. | 23,460 4.200% | -23,570![]() (-50.12%) | Filing History |
| 2024-02-02 12:31 pm Sale | 2024-01-16 | 13D | ALLAKOS INC ALLK | RiverVest Venture Fund III, L.P. | 108,159 0.200% | -4,848,743![]() (-97.82%) | Filing History |
| 2023-05-30 4:52 pm Purchase | 2023-05-08 | 13D | RENEO PHARMACEUTICALS INC RPHM | RiverVest Venture Fund III, L.P. | 253,422 7.530% | 12,500![]() (+5.19%) | Filing History |
| 2023-05-30 4:48 pm Purchase | 2023-02-16 | 13D | SPRUCE BIOSCIENCES INC SPRB | RiverVest Venture Fund III, L.P. | 47,030 8.600% | 18,386![]() (+64.19%) | Filing History |

